Genitourinary Cancer
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
From the Journals
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
Feature
New Trials in Prostate Cancer: Could Your Patient Benefit?
Two new trials for patients with metastatic castration-resistant prostate cancer that involve remaining on therapy until disease progression...
From the Journals
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
Feature
Prostate Cancer Tsunami Coming, Experts Caution
Expert suggests approaches for enabling earlier diagnosis of prostate cancer in men in low- to middle-income countries.
Commentary
A Banned Chemical That Is Still Causing Cancer
This carcinogen ‘is still around: in our soil, in our food, and in our blood.’
Conference Coverage
Money, Ethnicity, and Access Linked to Cervical Cancer Disparities
An online analytic tool provides visual evidence of the geographic and demographic disparities in incident and recurrent/metastatic cervical...
From the Journals
Active Surveillance for Cancer Doesn’t Increase Malpractice Risk
Researchers identify malpractice trends involving active surveillance related to thyroid, prostate, kidney, and...
Feature
Women’s Cancers: Clinicians Research, Advise on Sexual Dysfunction
New research highlights the importance of discussing risks of sexual dysfunction in patients with women’s cancers.
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
Latest News
New Guidelines: Start PSA Screening Earlier in Black Men
Multidisciplinary panel suggests lowering the screening age to 40-45 for PSA testing in Black men.